ALEUP — Europlasma SA Cashflow Statement
0.000.00%
- €0.00m
- €9.37m
- €70.42m
Annual cashflow statement for Europlasma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.7 | -15.8 | -14.7 | -15.9 | -37.9 |
| Depreciation | |||||
| Non-Cash Items | 0.835 | -1.92 | -3.1 | -7.46 | 8.73 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -9.05 | 6.29 | 0.559 | -0.532 | 4.84 |
| Change in Taxes Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -18.2 | -5.14 | -9.97 | -10.9 | -14.9 |
| Capital Expenditures | -5.43 | -2.9 | -1.73 | -1.52 | -5.46 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.272 | -1.25 | 0.781 | -0.574 | 5.04 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.7 | -4.16 | -0.953 | -2.09 | -0.42 |
| Financing Cash Flow Items | -0.12 | -5.34 | -0.469 | 4.42 | -1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 22.1 | 9.23 | 9.67 | 13.6 | 21 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.68 | -0.062 | -1.25 | 0.587 | 5.71 |